Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Improving intradermal drug delivery by highly accurate injection of small volumes in the skin

Latest news

CE-IVD marked

Colli-Pee® Small Volumes Products CE Marked

Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.

Latest blogpost

Vaccines play a critical role in protecting people against disease. HPV vaccination is primarily used for young girls, but is also recommended for boys. This blog explains the potential of HPV vaccination in reducing HPV-related cancers for girls and boys.

Upcoming event

Knowledge for Growth

Knowledge for Growth - Postponed to September

Ghent
Novosanis team members will attend the Knowledge for Growth congress in Ghent, Belgium; which will take place on 10 September 2020. Our team is excited to meet you there and give you more information about our unique urine capturing device Colli-Pee. This info will be shared by presenting a poster...